gemcitabine [clinicaltrials_resource:112b1e1f99c20b4552ad4ae51560a5f2]
intervention [clinicaltrials_vocabulary:intervention]
gemcitabine [clinicaltrials_resource:112b1e1f99c20b4552ad4ae51560a5f2]
Bio2RDF identifier
112b1e1f99c20b4552ad4ae51560a5f2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:112b1e1f99c20b4552ad4ae51560a5f2
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
2500 milligrams per square meter (mg/m2), intravenous (IV), every 14 days x 8 cycles
intervention name [clinicaltrials_vocabulary:intervention-name]
gemcitabine
other name [clinicaltrials_vocabulary:other-name]
identifier
clinicaltrials_resource:112b1e1f99c20b4552ad4ae51560a5f2
title
gemcitabine
@en
type
label
gemcitabine [clinicaltrials_resource:112b1e1f99c20b4552ad4ae51560a5f2]
@en